Is Accelerated Aging Tied to Early-Onset Carcinogenesis?
-
By
-
Andrea Surnit
-
June 26, 2026
-
4 min
By
Andrea Surnit
June 26, 2026
Oral orforglipron could be more effective in reducing hemoglobin A1c and body weight, with no increased risk of hypoglycemia in patients with inadequately controlled type 2 diabetes.
June 12, 2026
In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.
June 10, 2026